Young child receiving peanut-based therapeutic food treatment for severe malnutrition in developing country

New Deal Cuts Child Malnutrition Treatment Price by 30%

🦸 Hero Alert

A groundbreaking agreement just made life-saving malnutrition treatment affordable enough to reach a million more children without any new funding. The deal drops the price of a critical peanut-based treatment by 30 percent, turning existing dollars into exponentially more saved lives.

A million more children could survive severe malnutrition thanks to a deal that just slashed treatment costs by nearly a third.

The Clinton Health Access Initiative secured a new price of $32.50 per box for Ready-to-Use Therapeutic Food, the peanut-based paste that serves as the standard treatment for severe wasting in young children. That's 30 percent below the global average price and the lowest rate available anywhere in the world.

Indian manufacturer Vista Fortifoods committed to this price for governments, nonprofits, and humanitarian agencies working across dozens of low and lower-income countries. The deal requires minimum orders of 30,000 boxes, and buyers cover their own shipping from the factory.

The timing couldn't be more critical. Acute hunger has doubled over the past decade, with catastrophic hunger up ninefold since 2016. Two famines were declared in 2025 alone, and a collapse in nutrition funding threatens to cut off support for more than 2.3 million severely malnourished children across 18 countries.

Here's the remarkable part: if just 10 percent of current spending shifts to this lower price, a million more children could receive treatment without a single new donor dollar. Every box that used to treat two children can now treat three.

New Deal Cuts Child Malnutrition Treatment Price by 30%

"Severe wasting affects around 12 million children worldwide and is one of the leading causes of death in young kids, but it is entirely treatable," said CHAI CEO Dr. Neil Buddy Shah. Nine in ten children who complete treatment recover within four to six weeks.

The lower price doesn't mean lower quality. Vista is approved by UNICEF's Supply Division and produces to UNICEF's technical specifications and international food safety guidelines.

The Ripple Effect

Ghana has already proven what affordable pricing can do. Thanks to a similar partnership in 2024 that achieved the same 30 percent price reduction, the country more than doubled the number of malnourished children receiving treatment.

"Children who would have gone untreated due to stockouts related to high pricing are alive and recovering today," said Dr. Edward Bright Agyekum, Director of Procurement and Supply Chain for Ghana's Ministry of Health. "Any country that gets access to a lower price can expect the same kind of impact."

This treatment works anywhere. Because it needs no water, refrigeration, or preparation, it reaches children even in conflict zones and remote areas where hospital care isn't possible. It's the World Health Organization's recommended first-line treatment for severe wasting, the deadliest form of child malnutrition.

The deal shows that strategic procurement can reshape entire markets, and a million children might soon have the chance to prove it works.

Based on reporting by Google News - New Treatment

This story was written by BrightWire based on verified news reports.

Spread the positivity!

Share this good news with someone who needs it

More Good News